BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/3/2016 8:11:00 AM | Browse: 1407 | Download: 2486
 |
Received |
|
2016-04-01 09:05 |
|
Peer-Review Started |
|
2016-04-06 16:45 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-05-18 18:10 |
|
Revised |
|
2016-06-07 20:34 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-06-30 08:39 |
|
Second Decision by Editor-in-Chief |
|
2016-07-01 08:33 |
|
Final Decision by Editorial Office Director |
|
2016-07-13 12:16 |
|
Articles in Press |
|
2016-07-13 12:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-07-25 12:10 |
|
Publish the Manuscript Online |
|
2016-08-03 08:12 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Katriina Nemes, Fredrik Åberg, Helena Gylling and Helena Isoniemi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Katriina Nemes, MD, PhD, University of Helsinki and Helsinki University Central Hospital, Transplantation and Liver Surgery Clinic, Meilahti Hospital, P.O. BOX 340, FI-00029 HUS, Finland. katriina.nemes@outlook.com |
| Key Words |
Cholesterol metabolism; Cholestasis; Liver transplantation; Non-cholesterol sterols; Cholestanol; Donor; Low density lipoprotein receptor mutation; Apolipoprotein B-100; Lipoprotein-X |
| Core Tip |
The liver plays key roles in cholesterol meta-bolism. Cholestatic liver disease leads to alterations of cholesterol metabolism: Cholesterol homeostasis is disturbed and cholesterol synthesis and especially cholesterol absorption are reduced, and lipoprotein X may develop. The latter can interfere with cardiovascular risk assessment. Apolipoprotein B-100 measurement may be useful in such cases. Cholesterol metabolism in cholestasis could be better described using cholesterol precursor sterols, diet-derived plant sterols, and cho-lestanol (the liver-synthesized derivate of cholesterol). Accurate lipid profile evaluation is particularly important after liver transplantation, when both atherogenic and non-atherogenic hypercholesterolemia may co-exist. |
| Publish Date |
2016-08-03 08:12 |
| Citation |
Nemes K, Åberg F, Gylling H, Isoniemi H. Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications. World J Hepatol 2016; 8(22): 924-932 |
| URL |
http://www.wjgnet.com/1948-5182/full/v8/i22/924.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v8.i22.924 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
